quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:16:22·9h
INSIDERFiling
Texas Capital Bancshares Inc. logo

Director Ragusa Elysia Holt converted options into 1,670 shares, increasing direct ownership by 10% to 18,795 units (SEC Form 4)

TCBI· Texas Capital Bancshares Inc.
Finance
Original source

Companies

  • TCBI
    Texas Capital Bancshares Inc.
    Finance

Recent analyst ratings

  • Jan 27UpdateHovde Group$102.00
  • Oct 23UpdateHovde Group$93.00
  • Jul 18UpdateHovde Group$95.00
  • May 21UpdateJefferies$80.00
  • Apr 21UpdateHovde Group$75.00
  • Mar 7UpdateHovde Group$84.00

Related

  • INSIDER9h
    Director Hyle Charles S converted options into 1,670 shares, increasing direct ownership by 12% to 16,020 units (SEC Form 4)
  • INSIDER9h
    Director Whitley Laura L converted options into 1,670 shares, increasing direct ownership by 21% to 9,631 units (SEC Form 4)
  • INSIDER9h
    Director Stallings Robert W converted options into 1,670 shares, increasing direct ownership by 0.57% to 294,961 units (SEC Form 4)
  • INSIDER9h
    Director Tremblay Dale W converted options into 1,670 shares, increasing direct ownership by 10% to 17,995 units (SEC Form 4)
  • INSIDER9h
    Director Rosenberg Steve converted options into 1,670 shares, increasing direct ownership by 62% to 4,377 units (SEC Form 4)
  • INSIDER9h
    Director Midkiff Mark W converted options into 1,670 shares, increasing direct ownership by 147% to 2,804 units (SEC Form 4)
  • INSIDER9h
    Director Long Thomas E converted options into 1,670 shares, increasing direct ownership by 16% to 12,173 units (SEC Form 4)
  • INSIDER9h
    Director Huntley David S. converted options into 1,670 shares, increasing direct ownership by 15% to 12,468 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022